In silico analysis revealed a higher GD3S expression in ER− than ER+ breast cancers; GD3S was also highly expressed in triple negative breast cancers when compared to other types of breast cancers. This evidence concerns the gene ST8SIA1 and triple-negative breast carcinoma.